COVID-19: mRNA Vaccines; Antihypertensives and Risk; Fraudulent Antibody Tests

Inbox

x

MPR Daily Dose <editor@email.empr.com> Unsubscribe

May 10, 2020, 7:01 PM (19 hours ago)

to me

If you are having trouble viewing this email, click here.

TOP TRENDING COVID-19 mRNA Vaccine Candidates Advancing Through the Pipeline Antihypertensive Medication Use Not Linked to Risk for COVID-19 FDA Goes After Unproven COVID-19 Antibody Tests FDA Issues Emergency Use Authorization for Remdesivir Boxed Warning Added to Montelukast Labeling Regarding Neuropsychiatric Events Celecoxib Oral Solution Approved for Acute Migraine Treatment Farxiga Approved for Heart Failure With Reduced Ejection Fraction Guidelines Issued for Managing Eosinophilic Esophagitis Microbiome-Based Therapy Looks Promising for Recurrent C. Difficile Infection Fensolvi Approved for Central Precocious Puberty CME/CE Spotlight Dispelling the Myths of Influenza Management AMA PRA Category 1 Credit(s)TM, CNE Contact Hour(s), CE for Pharmacists CLICK HERE FOR A FULL LIST OF COURSES CE/CME Powered By myCME